The global muscle relaxant drug market is projected to grow significantly during the forecast period. Muscle relaxants are utilized to relax and reduce tension in the muscle. It primarily cures two conditions including spasticity or rigidness of the muscles caused by cerebral palsy, multiple sclerosis; and muscle spasms which are tension headache, low back pain, or fibromyalgia. Some of the commonly used drugs include methocarbamol, baclofen, and tizanidine that blocks over-excited neuronal pathways in the brain or spinal cord. Whereas dantrolene and botulinum toxins act directly on the muscle.
Get Free Sample link @ https://www.omrglobal.com/request-sample/muscle-relaxant-drug-market
The key factors that drive the growth of the market include the rising geriatric population. The aging population is projected to increase significantly during the forecast period. According to WHO, the geriatric population is going to be double in 2050 as compared to 2000. Globally, in 2000, the proportion of the population over 65 years was 11.0%, which is expected to reach 22.0% by 2050. Older age is a primary risk factor, as they are more prone to diseases as well as muscle and joint pains. Thus, this is likely to increase the growth of the market during the forecast period.
A full report of Global Muscle Relaxant Drug Market Size available @ https://www.omrglobal.com/industry-reports/muscle-relaxant-drug-market
- Market Coverage
- Market number available for – 2022-2028
- Base year- 2021
- Forecast period- 2022-2028
- Segment Covered- By Source, By Product Type, By Applications
- Competitive Landscape- Archer Daniels Midland Co., Ingredion Inc., Kerry Group Plc, Cargill Inc., and others
Market Segmentation
Global Muscle Relaxant Drug Market by Product Type
- Peripherally Acting Muscle Relaxants
- Facial Aesthetic Relaxants
- Centrally Acting Muscle Relaxants
Global Muscle Relaxant Drug Market by Formulation
- Oral
- Injectable
Regional Analysis
- North America
- United States
- Canada
- Europe
- UK
- Germany
- Italy
- Spain
- France
- Rest of Europe
- Asia-Pacific
- China
- India
- Japan
- Rest of Asia-Pacific
- Rest of the World
Company Profiles
- AbbVie Inc.
- Acorda Therapeutics Inc.
- Aurobindo Pharma Ltd.
- Cadila Healthcare Ltd.
- DBL Pharma Inc.
- Reddy’s Laboratories Ltd.
- Endo Pharmaceuticals Inc.
- Ipsen Biopharmaceuticals Inc.
- Johnson & Johnson Services Inc.
- Merck & Co. Inc.
- Mylan NV
- Neurana Pharmaceuticals
- Novartis International AG
- Orient Pharma Co. Ltd.
- Par Pharmaceutical Inc.
- Pfizer Inc.
- Vertical Pharmaceuticals LLC
The Report Covers
- Market value data analysis of 2019 and forecast to 2026.
- Annualized market revenues ($ million) for each market segment.
- Country-wise analysis of major geographical regions.
- Key companies operating in the global muscle relaxant drugs market. Based on the availability of data, information related to pipeline products, and relevant news is also available in the report.
- Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
- Analysis of market-entry and market expansion strategies.
- Competitive strategies by identifying ‘who-stands-where’ in the market.
For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/muscle-relaxant-drug-market
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 780-304-0404
